New Zealand markets open in 1 hour 44 minutes

Cognition Therapeutics, Inc. (CGTX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.1000+0.1400 (+7.14%)
At close: 04:00PM EDT
2.1000 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 78.51M
Enterprise value 44.88M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.72
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.44

Trading information

Stock price history

Beta (5Y monthly) 1.53
52-week change 3-9.26%
S&P500 52-week change 326.49%
52-week high 33.4900
52-week low 30.9000
50-day moving average 31.9194
200-day moving average 31.6902

Share statistics

Avg vol (3-month) 3159.34k
Avg vol (10-day) 398.63k
Shares outstanding 540.06M
Implied shares outstanding 641.95M
Float 833.89M
% held by insiders 10.47%
% held by institutions 133.45%
Shares short (30 Apr 2024) 4172.29k
Short ratio (30 Apr 2024) 41.36
Short % of float (30 Apr 2024) 40.62%
Short % of shares outstanding (30 Apr 2024) 40.43%
Shares short (prior month 28 Mar 2024) 4150.21k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-82.61%
Return on equity (ttm)-89.00%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -55.75M
Net income avi to common (ttm)-28.77M
Diluted EPS (ttm)-0.9200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)34.67M
Total cash per share (mrq)0.87
Total debt (mrq)1.03M
Total debt/equity (mrq)3.58%
Current ratio (mrq)3.99
Book value per share (mrq)0.72

Cash flow statement

Operating cash flow (ttm)-20.56M
Levered free cash flow (ttm)-27.67M